The effect of antitumor therapy on the reproductive system, the possibility of preserving female fertility
- 11 May 2024
- journal article
- research article
- Published by Alfmed LLC in Medical alphabet
- No. 8,p. 41-47
Abstract
The influence of malignant neoplasms and their treatment methods on the reproductive function of women is one of the significant problems of oncogynecology. The mechanisms of ovarian follicle loss caused by chemotherapy have their own characteristics depending on the characteristics of the cytotoxic agent and act differently on different populations of ovarian cells. The toxic effect on fertility of the main groups of antitumor drugs is considered. Reproductive dysfunction has negative consequences for a woman’s physical and mental health. The use of methods that reduce the effect of cytotoxic agents on the ovary helps to prevent premature ovarian insufficiency, leading to infertility. The article discusses modern methods of fertility preservation using assisted reproductive technologies. All cancer patients of reproductive age should receive full oncofertility counseling as early as possible, during the treatment planning process, regardless of the type and stage of the disease.Keywords
This publication has 29 references indexed in Scilit:
- The need to reduce gonadotoxicity! fertility reserve after chemotherapy for gynaecological cancerGynecological Endocrinology, 2021
- Ice age: Cryopreservation in assisted reproduction – An updateReproductive Biology, 2019
- Pregnancy after cancer: Does timing of conception affect infant health?Cancer, 2018
- Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohortThe Lancet Oncology, 2016
- Prevention of chemotherapy-induced ovarian damageFertility and Sterility, 2016
- Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adultsThe Lancet Diabetes & Endocrinology, 2015
- Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapyFertility and Sterility, 2013
- Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancerJournal of Assisted Reproduction and Genetics, 2010
- Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced deathNature Medicine, 2009
- Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinantsNature Reviews Cancer, 2006